Ms. Sonal Dushyant Patel, a member of the promoter group at Crestchem Limited , sold 9,305 equity shares through open market transactions on June 23, 2026. The sale reduced her total holding in the company to 5,295 shares, representing a reduction in her stake from 0.48% of the equity share capital. The transaction was conducted as a market sale, with the total value of the disposed shares amounting to ₹12,96,822.

Crestchem Limited disclosed the transaction to BSE Limited on June 24, 2026, pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The disclosure was submitted in Form C, which details the continual disclosure requirements for insiders. Ms. Patel is identified as the sister of a promoter in the company's records.

Transaction Details

The filing provides a breakdown of the shareholding changes and the specific transaction details. The table below outlines the movement of securities and the financial metrics of the sale.

The company confirmed that there was no trading in derivatives by the insider during the relevant period. Nitin Shantilal Shah, the Compliance Officer and Company Secretary of Crestchem Limited, signed the disclosure submitted to the exchange.

Crestchem Limited reported a standalone net profit of ₹110.38 lakh for the quarter ended March 31, 2026, rising from ₹61.04 lakh in the corresponding period of the previous year. Revenue from operations for the quarter stood at ₹1,022.53 lakh, compared to ₹723.20 lakh in Q4FY25. For the full financial year ended March 31, 2026, the company recorded a net profit of ₹271.35 lakh on revenue of ₹2,960.74 lakh.

The board of directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Additionally, the board recommended a final dividend of ₹1.50 per equity share, or 15%, for the financial year 2025-26. This dividend is subject to the approval of shareholders at the upcoming 34th Annual General Meeting.

During the financial year, the company incorporated a subsidiary, Oleo Biosciences Private Limited, in Bangalore, Karnataka, on March 31, 2026. Crestchem holds a 75% stake in the new entity. The subsidiary has not commenced commercial operations, and no significant financial transactions were carried out during the year, except for the recognition of subscription money.

The board approved the reappointment of three key managerial personnel for a five-year term. Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nimit Patel were reappointed for periods ranging from April 1, 2026, to October 1, 2031. Furthermore, the board authorized an investment of up to ₹2.25 crore in the new subsidiary through loans, inter-corporate deposits, or equity share capital.

The financial results were reviewed by the audit committee and subsequently taken on record by the board on May 29, 2026. Samir M. Shah & Associates, Chartered Accountants, audited the standalone and consolidated financial results.

Standalone Financial Results